Abstract
Traditional Chinese medicine (TCM) holds a holistic theory, and specializes in balancing disordered human body using numerous natural products, particularly Chinese herbal formulae. TCM has certain treatment advantages for patients suffering from various complex diseases. However, due to the complex nature of TCM, it remains difficult to unveil such holistic medicine by the current reductionism research strategies, which treat both herbal ingredients and targets in isolation. Recently, an emerging network pharmacology approach has been introduced to tackle this bottleneck problem. A TCM-derived novel therapeutic concept, "network target", which is different from the Western medicine's "onetarget" concept, has been proposed from China. The network target strategy is able to illustrate the complex interactions among the biological systems, drugs, and complex diseases from a network perspective, and thus provides an innovative approach to access ancient remedies in a precision manner and at a systematic level, which also highlights TCM's potential in current medical systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol 2007;1:51–60.
Li S. Framework and practice of network-based studies for Chinese herbal formula. J Chin Integr Med (Chin) 2007;5:1–5.
Hopkins AL. Network pharmacology. Nat Biotechnol 2007;25:1110–1111.
Li S. Network target: a starting point for traditional Chinese medicine network pharmacology. China J Chin Mater Med (Chin) 2011;15:2017–2020.
Li S, Zhang B, Zhang N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol 2011;5(Suppl 1):S10.
Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 2013;11:110–120.
Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4:682–690.
Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature 2009;461:218–223.
Li S, Zhang B, Jiang D, Wei YY, Zhang NB. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010;11(Suppl 11):S6.
Li S. Mapping ancient remedies: applying a network approach to traditional Chinese medicine. Science 2015;350:S72–S75.
Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011;12:56–68.
Vidal M, Cusick ME, Barabási AL. Interactome networks and human disease. Cell 2011;144:986–998.
Li S. Network systems underlying traditional Chinese medicine syndrome and herb formula. Curr Bioinf 2009;4:188–196.
Zhao S, Li S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One 2010;5:e11764.
Wu X, Jiang R, Zhang MQ, Li S. Network-based global inference of human disease genes. Mol Syst Biol 2008;4:189.
Yan H, Zhang B, Li S, Zhao Q. A formal model for analyzing drug combination effects and its application in TNF-alphainduced NFkappaB pathway. BMC Syst Biol 2010;4:50.
Zhao S, Li S. A co-module approach for elucidating drugdisease associations and revealing their molecular basis. Bioinformatics 2012;28:955–961.
Wang L, Wang Y, Hu Q, Li S. Systematic analysis of new drug indications by drug-gene-disease coherent subnetworks. CPT Pharmacometrics Syst Pharmacol 2014;3:e146.
Strohl WR. The role of natural products in a modern drug discovery program. Drug Discov Today 2000;5:39–41.
Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217–1220.
Zhang T. Studies on treatment of leukemia with traditional Chinese Drugs containing arsenic. Chin J Integr Med 1999;5:89–94.
Li Y, Li R, Ouyang Z, Li S. Herb network analysis for a famous TCM doctor's prescriptions on treatment of rheumatoid arthritis. Evid Based Complement Alternat Med 2015;2015:451319.
Zhang B, Wang X, Li S. An integrative platform of TCM network pharmacology and its application on a herbal formula, Qing-Luo-Yin. Evid Based Complement Alternat Med 2013;2013:456747.
Zhang Y, Bai M, Zhang B, Liu C, Guo Q, Sun Y, et al. Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation. Sci Rep 2015;5:9463.
Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang Pill as a case study. Mol Biosyst 2014;10:1014–1022.
Lee SH, Kim CE, Lee IS, Jung WM, Kim HG, Jang H, et al. Network analysis of acupuncture points used in the treatment of low back pain. Evid Based Complement Alternat Med 2013:402180.
Kim H, Ryu J, Lee J, Lee S. A systems approach to traditional oriental medicine. Nat Biotechnol 2015;33:264–268.
Patwardhan B, Chandran U. Network ethnopharmacology approaches for formulation discovery. Indian J Tradit Knowledge 2015;14:574–580.
Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol 2015;35(Suppl):S276–S304.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Natural Science Foundation of China (No. 81225025 and 91229201)
Rights and permissions
About this article
Cite this article
Li, S. Exploring traditional chinese medicine by a novel therapeutic concept of network target. Chin. J. Integr. Med. 22, 647–652 (2016). https://doi.org/10.1007/s11655-016-2499-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-016-2499-9